{{Rsnum
|rsid=119774
|Gene=ABCC1
|Chromosome=16
|position=15992976
|Orientation=minus
|GMAF=0.03765
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCC1
}}{{PharmGKB
|RSID=rs119774
|Name_s=MRP1 (rs119774)
|Gene_s=ABCC1
|Feature=Intron
|Evidence=PubMed ID:16293801
|Annotation=Associations were found between genotypes of SNPs in the ALOX5 (rs2115819) and MRP1 (rs119774) genes and changes in FEV(1) (p < 0.05) in asthma patients treated with montelukast.
|Drugs=montelukast
|Drug Classes=
|Diseases=Asthma
|Curation Level=Curated
|PharmGKB Accession ID=PA162652700
}}

{{PMID|19077707|OA=1
}} Pharmacogenetics of asthma.

{{PMID|19214143|OA=1
}} 5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci.

{{PMID|19665766|OA=1
}} Genetics and pharmacogenetics of the leukotriene pathway.

{{PMID|20592916|OA=1
}} Pharmacogenomic approaches to asthma treatment.

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs119774
|overall_frequency_n=6
|overall_frequency_d=128
|overall_frequency=0.046875
|n_genomes=3
|n_genomes_annotated=0
|n_haplomes=4
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}